Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

 

Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
D

COVID-19 Treatment Q&A: Do Treatment Reccomendations Differ for Patients Who Do Not Require Hospitalization But Have Risk Factors for VTE?

By Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient FEATURING David Porter, Ravi Amaravadi, Adam C. Cuker
By Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient FEATURING David Porter, Ravi Amaravadi, Adam C. Cuker
32 views
February 23, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

18:30
Pfizer Hematology

Expert Case Review: A Treatment Option for Adult Patients With Stage…

Feat. A. Whiteley

Featured Video

19:25
Pfizer Hematology

Moving Forward in Stage III/IV Classical Hodgkin Lymphoma

Feat. A. Ip
COVID-19
11:33

COVID-19 Treatment Q&A: Do Treatment Reccomendations Differ for Pati…

Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

D. Porter, R. Amaravadi, A. Cuker

32 views
16:06

Does the Risk of COVID-19-Associated VTE Increase With Illness Sever…

Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

A. Cuker

53 views
17:30

Drug Repurposing for COVID-19 Therapy: How Are Physicians Repurposin…

Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

R. Amaravadi

6 views